OraSure Technologies, Inc. Stock price

Equities

OSUR

US68554V1089

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
6.15 USD +0.16% Intraday chart for OraSure Technologies, Inc. -5.67% -25.00%
Sales 2024 * 191M Sales 2025 * 167M Capitalization 453M
Net income 2024 * -9M Net income 2025 * -18M EV / Sales 2024 * 0.92 x
Net cash position 2024 * 277M Net cash position 2025 * - EV / Sales 2025 * 2.72 x
P/E ratio 2024 *
-51.8 x
P/E ratio 2025 *
-25.6 x
Employees 638
Yield 2024 *
-
Yield 2025 *
-
Free-Float 95.18%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on OraSure Technologies, Inc.

1 day+0.16%
1 week-5.67%
Current month-14.52%
1 month-12.52%
3 months-26.35%
6 months+4.95%
Current year-25.00%
More quotes
1 week
6.08
Extreme 6.08
6.38
1 month
6.08
Extreme 6.08
7.81
Current year
6.08
Extreme 6.08
8.45
1 year
4.38
Extreme 4.375
8.45
3 years
2.62
Extreme 2.62
13.57
5 years
2.62
Extreme 2.62
19.75
10 years
2.62
Extreme 2.62
23.01
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 22-06-03
Director of Finance/CFO 52 22-08-07
Chief Operating Officer - 22-06-30
Members of the board TitleAgeSince
Director/Board Member 61 19-08-10
Director/Board Member 64 20-04-05
Chairman 61 17-06-21
More insiders
Date Price Change Volume
24-03-28 6.15 +0.16% 1,183,388
24-03-27 6.14 +0.99% 739,040
24-03-26 6.08 -2.25% 626,838
24-03-25 6.22 -1.58% 773,730
24-03-22 6.32 -0.32% 707,590

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
6.15 USD
Average target price
7.65 USD
Spread / Average Target
+24.39%
Consensus
  1. Stock
  2. Equities
  3. Stock OraSure Technologies, Inc. - Nasdaq